{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Theraclone Sciences", "item": "https://www.patentleaderboard.com/2021/company/theraclone-sciences"}, {"@type": "ListItem", "position": 4, "name": "Ole Olsen", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ol_ln:olsen-7"}]}

Home › 2021 › Theraclone Sciences › Ole Olsen

Ole Olsen — 1 Patent in 2021

IBIgm Biosciences: 1 patents #4 of 7Top 60%

Everett, WA: #49 of 138 inventorsTop 40%

Washington: #4,694 of 13,672 inventorsTop 35%

Overall (2021): #312,413 of 548,734Top 60%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11192941	Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof	Bruce Keyt, Dan T. Stinchcomb	2021-12-07	$29,789,000

Ole Olsen — 1 Patent in 2021

Issued Patents 2021

Patent Widget